GSE143782 calcitriol 6 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE143782_calcitriol_6_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE143782_calcitriol_6_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE143782_calcitriol_6_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE143782_calcitriol_6_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

cytochrome P450 family 2 subfamily B member 7, pseudogene

Gene

vesicle associated membrane protein 7

Gene

notch 2 N-terminal like B

Gene

long intergenic non-protein coding RNA 649

Gene

uncharacterized LOC645485

Gene

mitotically associated long non coding RNA

Gene

MIR31 host gene

Gene

WARS2 antisense RNA 1

Gene

long intergenic non-protein coding RNA 3052

Gene

FTX transcript, XIST regulator

  • Gene

    cytochrome P450 family 2 subfamily B member 7, pseudogene


  • Gene

    vesicle associated membrane protein 7


  • Gene

    notch 2 N-terminal like B


  • Gene

    long intergenic non-protein coding RNA 649


  • Gene

    uncharacterized LOC645485


  • Gene

    mitotically associated long non coding RNA



  • Gene

    WARS2 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 3052


  • Gene

    FTX transcript, XIST regulator

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.